The recent clearance reconfirms the freedom to utilize the entire volume of EQUASHIELD’s Syringe Unit, leading to enhanced cost savings and safety with handling of hazardous drugs.
PORT WASHINGTON, N.Y., Oct. 3, 2023 /PRNewswire/ — EQUASHIELD®, a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, is thrilled to announce that its EQUASHIELD® Syringe Unit has received FDA clearance for full-volume use: “The system’s closed Syringe Unit prevents intended and unintended syringe plunger detachment and can be used safely up to its maximal nominal volume with hazardous drugs” 1.